Evidence map›Paper›PMID 32366719›Full record

ArticleAntimicrobial agents and chemotherapy2020

Combination Therapy Using Benznidazole and Aspirin during the Acute Phase of Experimental Chagas Disease Prevents Cardiovascular Dysfunction and Decreases Typical Cardiac Lesions in the Chronic Phase.

Rito Santo Pereira, Aparecida Donizette Malvezi, Maria Isabel Lovo-Martins, Bruno Fernando Cruz Lucchetti, Jussevania Pereira Santos, Eliandro Reis Tavares, Waldiceu Aparecido Verri, Eduardo José de Almeida Araújo, Lucy Megumi Yamauchi, Sueli Fumie Yamada-Ogatta and 2 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The roles of COX-2 in protozoan infection.Frontiers in immunology · 2023
    Review
  6. Lipoxin alleviates oxidative stress: a state-of-the-art review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Review
  7. Review
  8. Review on Experimental Treatment Strategies AgainstJournal of experimental pharmacology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rito Santo PereiraLaboratório de Imunopatologia Experimental, Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Aparecida Donizette MalveziLaboratório de Imunopatologia Experimental, Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Maria Isabel Lovo-MartinsLaboratório de Imunopatologia Experimental, Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Bruno Fernando Cruz LucchettiLaboratório de Fisiologia e Fisiopatologia Cardiovascular, Departamento de Ciências Fisiológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Jussevania Pereira SantosLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Eliandro Reis TavaresLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Waldiceu Aparecido VerriLaboratório de Pesquisa em Dor, Neuropatia e Inflamação, Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Eduardo José de Almeida AraújoLaboratório de Neurogastroenterologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, CEP, Londrina, Paraná, Brazil.
Lucy Megumi YamauchiLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Sueli Fumie Yamada-OgattaLaboratório de Biologia Molecular de Microrganismos, Departamento de Microbiologia, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Marli Cardoso Martins-PingeLaboratório de Fisiologia e Fisiopatologia Cardiovascular, Departamento de Ciências Fisiológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Phileno Pinge-FilhoLaboratório de Imunopatologia Experimental, Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina, Paraná, Brazil pingefilho@uel.br.ORCID 0000-0002-1500-3998

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chagas disease, caused by the protozoan

Indexed as

Chagas DiseaseNitroimidazolesTrypanocidal AgentsTrypanosoma cruziAnimalsAspirinDrug CombinationsHumansMiceAspirinbenzonidazoleDrug CombinationsNitroimidazolesTrypanocidal Agentsaspirinbenznidazolecardioprotective effectsChagas diseaselipoxintherapy

Identifiers

PMID32366719
PMCPMC7318042

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.